Thrivent Financial for Lutherans Cuts Stock Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Thrivent Financial for Lutherans lowered its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY – Get Rating) by 64.6% in the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 45,742 shares of the medical instruments supplier’s stock after selling 83,371 shares during the period. Thrivent Financial for Lutherans’ holdings in DENTSPLY SIRONA were worth $1,457,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in XRAY. Vanguard Group Inc. raised its stake in shares of DENTSPLY SIRONA by 1.2% in the third quarter. Vanguard Group Inc. now owns 24,732,513 shares of the medical instruments supplier’s stock valued at $701,167,000 after acquiring an additional 297,487 shares in the last quarter. Artisan Partners Limited Partnership boosted its stake in shares of DENTSPLY SIRONA by 3.7% in the 3rd quarter. Artisan Partners Limited Partnership now owns 13,229,926 shares of the medical instruments supplier’s stock valued at $375,068,000 after buying an additional 471,200 shares during the period. Nuance Investments LLC grew its position in shares of DENTSPLY SIRONA by 0.7% during the fourth quarter. Nuance Investments LLC now owns 12,642,319 shares of the medical instruments supplier’s stock worth $402,531,000 after buying an additional 92,591 shares in the last quarter. Cooke & Bieler LP increased its stake in shares of DENTSPLY SIRONA by 27.1% during the fourth quarter. Cooke & Bieler LP now owns 5,866,388 shares of the medical instruments supplier’s stock worth $186,786,000 after buying an additional 1,249,656 shares during the period. Finally, Wellington Management Group LLP raised its holdings in DENTSPLY SIRONA by 83.1% in the first quarter. Wellington Management Group LLP now owns 5,502,424 shares of the medical instruments supplier’s stock valued at $270,829,000 after acquiring an additional 2,497,773 shares in the last quarter. 98.52% of the stock is owned by hedge funds and other institutional investors.

DENTSPLY SIRONA Stock Down 0.8 %

DENTSPLY SIRONA stock opened at $40.19 on Monday. The stock has a 50-day simple moving average of $39.76 and a 200-day simple moving average of $35.85. The company has a market capitalization of $8.54 billion, a P/E ratio of 15.05, a PEG ratio of 2.30 and a beta of 0.91. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.93 and a current ratio of 1.41. DENTSPLY SIRONA Inc. has a fifty-two week low of $26.48 and a fifty-two week high of $43.24.

DENTSPLY SIRONA (NASDAQ:XRAY – Get Rating) last posted its quarterly earnings data on Wednesday, May 3rd. The medical instruments supplier reported $0.39 earnings per share for the quarter, beating the consensus estimate of $0.34 by $0.05. The business had revenue of $978.00 million during the quarter, compared to the consensus estimate of $938.16 million. DENTSPLY SIRONA had a positive return on equity of 8.65% and a negative net margin of 26.41%. The company’s revenue was up .9% compared to the same quarter last year. During the same period in the prior year, the company earned $0.52 earnings per share. Equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.91 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Friday, April 14th. Stockholders of record on Friday, March 31st were issued a $0.125 dividend. The ex-dividend date of this dividend was Thursday, March 30th. This represents a $0.50 dividend on an annualized basis and a dividend yield of 1.24%.

Insider Transactions at DENTSPLY SIRONA

In related news, SVP Cord Friedrich Staehler sold 4,000 shares of the business’s stock in a transaction dated Tuesday, March 7th. The stock was sold at an average price of $39.33, for a total value of $157,320.00. Following the transaction, the senior vice president now owns 97,693 shares in the company, valued at approximately $3,842,265.69. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In related news, SVP Cord Friedrich Staehler sold 4,000 shares of DENTSPLY SIRONA stock in a transaction on Tuesday, March 7th. The shares were sold at an average price of $39.33, for a total value of $157,320.00. Following the transaction, the senior vice president now directly owns 97,693 shares in the company, valued at approximately $3,842,265.69. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Eric Brandt sold 6,200 shares of the company’s stock in a transaction on Tuesday, May 2nd. The stock was sold at an average price of $42.17, for a total transaction of $261,454.00. Following the transaction, the director now owns 44,902 shares of the company’s stock, valued at approximately $1,893,517.34. The disclosure for this sale can be found here. Insiders own 0.74% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts have commented on XRAY shares. Robert W. Baird increased their price objective on shares of DENTSPLY SIRONA from $36.00 to $46.00 in a research report on Thursday, May 4th. Piper Sandler lifted their price target on DENTSPLY SIRONA from $29.00 to $35.00 and gave the stock a “neutral” rating in a report on Monday, February 6th. Barrington Research increased their price objective on DENTSPLY SIRONA from $43.00 to $51.00 in a report on Thursday, May 4th. Morgan Stanley raised their target price on DENTSPLY SIRONA from $39.00 to $45.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 19th. Finally, TheStreet raised DENTSPLY SIRONA from a “d+” rating to a “c” rating in a report on Tuesday, February 28th. Three investment analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $42.13.

About DENTSPLY SIRONA

(Get Rating)

Dentsply Sirona, Inc engages in the design, manufacture, sales and distribution of professional dental products and technologies. It operates through the following segments: Technologies and Equipment and Consumables. The Technologies and Equipment segments comprises dental technology, equipment and healthcare consumable products such as dental implants, laboratory dental products, computer-aided design and computer-aided manufacturing systems, imaging systems, treatment centers and consumable medical device products.